Crossmark

Comparison of 75 mg versus 150 mg aspirin for the prevention of preterm preeclampsia in high-risk women at a tertiary level hospital: study protocol for a randomized double-blind clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08520-z

Published Online: 2024-10-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saxena, Upma https://orcid.org/0000-0002-0472-9048
Lachyan, Abhishek https://orcid.org/0000-0002-4339-2070
Goyal, Chanchal

Kapoor, Garima

Agarwal, Kavita

Prasad, Sidarrth
Funding

Funding for this research was provided by:

Indian Council of Medical Research (171811)
License Information

Text and Data Mining valid from 2024-10-15

Version of Record valid from 2024-10-15
More Information

Article History

Received: 10 May 2024

Accepted: 1 October 2024

First Online: 15 October 2024

Declarations

:

: This study has been approved by the Institutional Ethics Committee S. No. IECVMMC/SJH/Project/2023–12/410 Dated 28/02/2023. All participants will provide written informed consent before enrollment in the study.

: Participants will provide consent for publication of anonymized data and study findings.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below